← Retour au Screener

Sector: Santé
Open in Terminal → STVNLive chart · Key metrics · News · Smart money

Stevanato Group

STVN Mid Cap

Healthcare · Medical Instruments & Supplies

Mis à jour: Jun 18, 2026, 22:21 UTC

15,35 €
+3.11% aujourd'hui
52W: 11,25 € – 24,43 €
52W Low: 11,25 € Position: 31.1% 52W High: 24,43 €

Price Chart

Indicateurs clés

P/E Ratio
29.81x
Cours/Bénéfice
Forward P/E
20.99x
P/E prévisionnel
P/S Ratio
3.99x
Cours/Ventes
EV/EBITDA
16.79x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
4,2 Md €
Capitalisation boursière
Croissance du CA
6.6%
Croissance du CA sur un an
Marge bénéficiaire
11.75%
Marge nette
ROE
9.59%
Rentabilité des capitaux propres
Beta
0.78
Sensibilité au marché
Positions vendeuses
2.06%
% du flottant vendu à découvert
Volume moyen
524,474
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
10 analysts
Avg. Price Target
21,69 €
+41.28% upside
Target Range
15,27 € – 27,93 €

About the Company

Sector: Healthcare Industry: Medical Instruments & Supplies Country: Italy Employees: 6,010 Exchange: NYQ

Stevanato Group en bref

Stevanato Group (STVN) is currently trading at 15,35 € with a market capitalization of 4,2 Md €. The trailing P/E ratio stands at 29.81x, with a forward P/E of 20.99x. The 52-week range spans from 11,25 € to 24,43 €; the current price is 37.2% below the yearly high. Year-over-year revenue growth stands at +6.6%. The net profit margin stands at 11.75%.

💰 Dividende

Stevanato Group currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

10 analystes évaluent Stevanato Group (STVN) au consensus : Acheter. L'objectif de cours moyen est de 21,69 €, soit un potentiel de +41.28% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 15,27 € à 27,93 €.

Stevanato Group : la thèse d'investissement en détail

Stevanato Group (STVN) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in Italy. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 41.28% upside from current levels — analyst sentiment is firmly constructive.

Valorisation en contexte

At a PEG of 3.57, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.

À surveiller

  • The forward P/E of 20.99x is meaningfully below the trailing 29.81x — analysts expect earnings to step up; the next earnings release is the test.
  • The analyst consensus price target implies 41.28% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Consensus des analystes : Buy
  • Bilan solide avec faible endettement (D/E 29.43)
Points faibles
  • Free cash flow négatif

Aperçu technique

MM 50 jours
14,88 €
+3.17% vs. cours
MM 200 jours
17,22 €
-10.85% vs. cours
Sous le plus haut 52s
−37.2%
24,43 €
Au-dessus du plus bas 52s
+36.5%
11,25 €

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

Risque de marché (Bêta)
0.78 · Défensive
Évolue moins que le marché global
Positions vendeuses
2.06% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
29.43 · Faible
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 14,88 €
200-Day MA: 17,22 €
Volume: 147,254
Avg. Volume: 524,474
Short Ratio: 2.22
P/B Ratio: 2.72x
Debt/Equity: 29.43x
Free Cash Flow: -49 794 128 €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Stevanato Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut